Synthesis, Characterization, and Antimicrobial Activities of Coordination Compounds of Aspartic Acid

Table 4

Antimicrobial activities of the compounds.

Microorganisms	E. coli	P. aeruginosa	P. vulgaris	S. aureus	B. subtilis	MRSA	C. albicans
Aspartic acid	6.0 ± 0.2	6.0 ± 0.7	6.0 ± 0.0	6.0 ± 0.1	6.0 ± 0.1	6.0 ± 0.5	8.0 ± 1.0
Cu(asp)2	6.0 ± 0.0	12.0 ± 0.3	6.0 ± 0.2	12.0 ± 0.7	12.0 ± 0.0	16.0 ± 0.5	6.0 ± 0.3
Cd(asp)2	8.0 ± 0.2	8.0 ± 0.0	6.0 ± 0.6	11.0 ± 0.1	8.0 ± 0.3	11.0 ± 0.0	17.0 ± 0
Ni(asp)2	6.0 ± 0.5	6.0 ± 0.1	6.0 ± 0.7	6.0 ± 1.0	6.0 ± 0.9	6.0 ± 0.2	6.0 ± 0.2
Co(asp)2	6.0 ± 0.6	6.0 ± 0.1	6.0 ± 0.1	6.0 ± 0.0	6.0 ± 0.0	6.0 ± 0.8	6.0 ± 0.6
Mn(asp)2	8.0 ± 0.5	8.0 ± 0.8	8.0 ± 0.3	14.0 ± 0.2	20.0 ± 0.5	10.0 ± 0.3	6.0 ± 0.4
Na2[Cu(asp)2]	9.0 ± 1.0	6.0 ± 0.3	10.0 ± 0.7	36.0 ± 0.8	16.0 ± 0.3	23.0 ± 0.8	16.0 ± 0.9
Na2[Cd(asp)2]	6.0 ± 0.0	11.0 ± 0.4	6.0 ± 1.0	10.0 ± 0.5	6.0 ± 0.6	6.0 ± 0.3	37.0 ± 0.1
Na2[Ni(asp)2]	8.0 ± 0.7	6.0 ± 0.8	6.0 ± 0.4	11.0 ± 0.9	13.0 ± 0.4	18.0 ± 0.3	15.0 ± 0.9
Na2[Co(asp)2]	14.0 ± 0.3	6.0 ± 0.5	6.0 ± 1.1	6.0 ± 0.2	10.0 ± 0.2	18.0 ± 0.1	17.0 ± 0.0
Na2[Mn(asp)2]	6.0 ± 0.7	6.0 ± 0.9	13.0 ± 0.0	6.0 ± 0.2	6.0 ± 0.7	13.0 ± 0.3	6.0 ± 0.1
C	20.0 ± 0.4	6.0 ± 0.0	15.0 ± 0.6	20.0 ± 0.2	6.0 ± 0.9	6.0 ± 0.7	19.0 ± 0.1

C: Acriflavine.
+: Gram-positive bacteria.
−: Gram-negative bacteria.